PPARa variant V227A reduces plasma triglycerides through enhanced lipoprotein lipolysis
Related Posts
Min JH, Chen PJ, Qureshi TA, Javed S, Xie Y, Azab L, Wang L, Kim HS, Li D, Yang JD. Prediction of Immunotherapy Response in[...]
Han S, Agopian VA, Steggerda JA, Kim IK, Sanford A, Lee YT, Kwon JH, Rhu JS, Kim GS, Yang JD. Impact of Donor Age on[...]
Shah T, Ansari Z, Ahmad A, Coyle W, Greenwald BB, Kachaamy T, Kothari S, Sharma N, Smallfield G, Thakkar S, Tsai F, Zhang H, Friedland[...]